Izzar Rachid — SEC Form 4 filings
SEC reporting owner CIK 1875506. 10 Form 4 filings on record with FilingPulse; latest filed 2026-02-17.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-31 to 2026-02-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 2,223 shares, $300,105 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 2,223 shares @ $135.00 ($300,105) in BIOGEN INC., filed 2025-07-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOGEN INC. (BIIB) | Head of Global Product Strat. | 10 | — | 1 leg · 2,223 sh · $300,105 | 35 |
Form 4 filings — Izzar Rachid
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-17 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 7,390 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 2,044 @ $0 · Tax withholding (F): 805 @ $201.18 · Option exercise (M): 1,802 @ $0 · Tax withholding (F): 458 @ $201.18 · Option exercise (M): 3,043 @ $0 · Tax withholding (F): 775 @ $201.18 · +3 more | EDGAR |
| 2025-07-16 | 4 | BIOGEN INC. (BIIB) | Sale (S): 2,223 @ $135 | EDGAR |
| 2025-02-12 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 1,515 @ $0 · Tax withholding (F): 445 @ $142.54 · Option exercise (M): 1,515 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 2,043 @ $0 · Tax withholding (F): 600 @ $141.35 · Tax withholding (F): 565 @ $141.35 · Option exercise (M): 1,801 @ $0 · Option exercise (M): 2,043 (derivative) @ $0 · Option exercise (M): 1,801 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 9,130 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 1,370 @ $0 · Tax withholding (F): 639 @ $219.08 · Option exercise (M): 647 @ $0 · Tax withholding (F): 313 @ $219.08 · Option exercise (M): 1,370 (derivative) @ $0 · Option exercise (M): 647 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-13 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 1,515 @ $0 · Tax withholding (F): 445 @ $240.98 · Option exercise (M): 1,515 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 2,043 @ $0 · Tax withholding (F): 621 @ $240.30 · Grant/award (A): 5,405 (derivative) @ $0 · Option exercise (M): 2,043 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 1,370 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1875506 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →